Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

1627824-09-2Sofosbuvir Impurity 65

● Auf Lager

Katalog-Nr.::	VE0022931
CAS-Nr.::	1627824-09-2
Summenformel::	C18H17F5NO5P
Molare Masse::	453.30 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 1627824-09-2

Parent drug

Sofosbuvir

IUPAC-Name

(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate

Pharmakopöe-Synonyme

N/A

Other Synonyms

Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-D-alaninate

SMILES

FC1=C(F)C(F)=C(F)C(F)=C1O[P@@](N[C@H](C)C(OC(C)C)=O)(OC2=CC=CC=C2)=O

InChI

InChI=1S/C18H17F5NO5P/c1-9(2)27-18(25)10(3)24-30(26, 28-11-7-5-4-6-8-11)29-17-15(22)13(20)12(19)14(21)16(17)23/h4-10H, 1-3H3, (H, 24, 26)/t10-, 30-/m1/s1

Beschreibung

Sofosbuvir Impurity 65 is a meticulously characterized reference material that complies with rigorous regulatory requirements | including those defined by USP | EMA | JP | and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial manufacturing of Sofosbuvir. It is further supported by a detailed Structure Elucidation Report (SER) | ensuring high accuracy and reliability across a broad range of analytical applications.